bioRxivCell BiologyPreprint
Reduced PABPN1 levels causes cytoskeleton disorganization and aberrant differentiation
V. Raz, E. van der Wal, C. Domagoj, C. S. Olie, L. Maton, J. C. de Greef, I.-H. Lin, Y.-F. Chen, E. Kareem, J. M. Penninger, B. Kessler
Abstract
The polyadenylation binding protein nucleus 1 (PABPN1), a multifactorial regulator of mRNA processing, regulates muscle wasting and atrophy. Previously, we elucidated the PABPN1-dependent proteome and found that levels of structural proteins, sarcomeric and cytoskeletal, were highly altered. We identified MURC, a plasma membrane-associated protein, to be affected by the cytoskeletal stability and suggest that MURC is a novel marker for impaired regeneration in muscles. We also studied the spatial organization of muscle structural proteins in 2D and 3D cell models with reduced PABPN1 levels (named here as shPAB). We show that dysregulation of cytoskeletal proteins in the shPab proteome is associated with a cytoskeleton lacking a polarized organization in muscle cells. We show that consequently, the cell mechanical features as well as myogenic differentiation are significantly reduced. We then show that restoring cytoskeletal stability, by actin overexpression in shPAB was beneficial for cell fusion and for the expression of sarcomeric proteins in shPAB models. We suggest that poor cytoskeleton mechanical features are caused by altered expression levels and contribute to aging-associated muscle wasting and atrophy.
- organism: mouse
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Correlating Protein Aggregate Structure with Cellular Function in Differentiated Muscle Cells: Discriminating Pathogenic from Non-Pathogenic Forms
Sander D. Mallon, Erik Bos, … Vered Raz·bioRxiv·Apr 25, 2024
- PABPN1 loss-of-function in oculopharyngeal muscular dystrophy primarily impacts APA-shift in muscle transcripts
Milad Shademan, Hailiang Mei, … Vered Raz·medRxiv·Aug 17, 2023
- Domain-specific regulation of PABPN1 uncouples aggregation from function and enables therapeutic rescue
Milad Shademan, Iolanda Vendrell, … Vered Raz·bioRxiv·Jun 16, 2026
- Muscle stem cells produce a protective Fibrillin-1 matrix to prevent precocious activation.
Eleni Chrysostomou, Oussama Smail, … Philippos Mourikis·bioRxiv·Aug 2, 2025
- Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics
Allison T. Mezzell, Alexandra M Perez, … Katherine E. Vest·PLoS GeneticsPeer-reviewed·Jan 26, 2026
- Dual roles of mTORC1-dependent activation of the ubiquitin-proteasome system in muscle proteostasis
M. S. Kaiser, G. Milan, … M. A. Ruegg·bioRxiv·Nov 16, 2021